Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities

Junshu Li1, Wencheng Zhou2, Huiling Wang1

  • 1Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy West China Hospital, Sichuan University Chengdu China.

Medcomm
|November 25, 2024
PubMed

Insights

Exosomal circular RNAs (circRNAs) are key regulators in cancer progression and the tumor microenvironment. These stable molecules show promise as diagnostic biomarkers and therapeutic targets for various cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Exosomes mediate intercellular communication by transferring genetic material, influencing cancer malignancy.
  • Exosomal circular RNAs (circRNAs) play critical roles in carcinogenesis, affecting tumor growth, metastasis, and drug resistance.

Purpose of the Study:

  • To review the regulatory roles of exosomal circRNAs in tumor progression and the tumor microenvironment (TME).
  • To summarize the intercellular transfer and impact of exosomal circRNAs within the TME.
  • To highlight the potential of exosomal circRNAs as biomarkers and therapeutic strategies in cancer.

Main Methods:

  • Literature review of recent studies on exosomal circRNAs in cancer.
  • Analysis of exosomal circRNA involvement in tumor-related signaling pathways.
  • Examination of exosomal circRNA transmission among cells in the TME.

Main Results:

  • Exosomal circRNAs regulate key cancer processes including growth, metastasis, angiogenesis, and immune escape.
  • Intercellular transfer of exosomal circRNAs among tumor cells, stromal cells, immune cells, and microbiota impacts tumor initiation and progression.
  • High stability and presence in biofluids make exosomal circRNAs promising diagnostic and prognostic biomarkers.

Conclusions:

  • Exosomal circRNAs are crucial regulators of cancer development and progression within the TME.
  • Exosomal circRNAs offer potential as non-invasive biomarkers for cancer diagnosis and prognosis.
  • Targeting exosomal circRNAs presents novel therapeutic strategies for cancer treatment.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K